Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 18 results for "bofa ml india"

BofA Cuts FY17 Growth Forecast to 6.9% Amid Demonetisation
News18.com

India's GDP To Come Down To 6.9%: BofA-ML

A Bank of America Merrill Lynch (BofA-ML) report has said that the Indian economy is going through a shallow recovery and GDP growth is expected to come down to 6.9 percent this fiscal following demonetisation.Commenting on the issue, a BofA-ML Official ... One India, 6 days ago
[x]  

1 images for "bofa ml india"

Financial Express, 1 month ago
Livemint.com

Sensex falls 1.5%, wipes out gains so far this year

Brokerages lower year-end targets for Sensex; rupee hits a fresh nine-month low Mumbai: India's benchmark indices, the Sensex and Nifty, on Monday erased all their gains so far this year and the rupee closed at a fresh nine-month low as foreign ...
 Livemint.com2 weeks ago

Aggregate growth for market not very robust: Sanjay Mookim, BofA ML

In a chat with , Sanjay Mookim, BofA ML, says a lot of earnings over the last four or five quarters have come from margin expansions and that will probably not continue. Edited excerpts What is happening, the earnings are not all that bad, I am ...
 Economic Times1 month ago
Rediff.com

CRR effect: Even as public pours in cash, banks scramble to manage liquidity

RBI on Monday conducted an unprecedented level of liquidity infusion to the tune of Rs 3.3 lakh crore, in which banks bid for as much as Rs 4.5 lakh crore. The central bank said it would conduct a liquidity infusion auction of Rs 1 lakh crore on Tuesday as well, to help banks tide over the liquidity crisis. Upset by the Reserve Bank of India’s decision to charge the entire deposits that banks collected between September 16 and November 11 as a reserve requirement, bankers have said they ...
 Rediff.com1 week ago

Near term growth concerns to weigh on Sun Pharma

Sun Pharma has acquired 85% stake in OJSC Biosintez, a Russian company. With that, it gets a facility in Russia, which saw total pharma distributor-to-retailer sales of $10 billion in 12 months to September 2016. Russia and Commonwealth of ...
 Smart Investor1 week ago

Demonetisation: investors to wait for stability, says Raj Balakrishnan

Modi govt's decision to demonetise Rs 500 and Rs 1,000 notes took investors off guard, just Trump's US election win did, says BofA-ML India head for investment banking
 Business Standard2 weeks ago

Scope For 0.5% Rate Cut From RBI By April: Bank Of America

Retail inflation in September dropped to a 13-month low of 4.31 per cent, mainly on account of easing vegetables prices, creating headroom for further rate cut by RBI in coming months. The RBI is expected to pause on the December 7 monetary ...
 NDTV1 month ago

DCB Bank, NIIT Tech, Crisil in focus post Q2 nos

Essar- Rosneft deal : Russian oil giant Rosneft has cemented the deal to buy 49 percent stake in Essar Oil. European commodities trader Trafigura and Russian fund UCP consortium will also pick up 49 percent stake in Essar, leaving existing promoters ...
 Moneycontrol.com1 month ago

Global monetary policies favour gold demand: WGC

Globally, investors are starting to lose confidence in the effectiveness of unconventional monetary policies, and are using gold to hedge portfolio risks as they add more stocks and low quality bonds to their asset mix, finds the World Gold Council. Investors ...
 The Financial Chronicle2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less